Hao Zheng is a visionary leader and the Co-founder and President of 锘崴科技, where he plays a pivotal role in advancing the field of bioinformatics and next-generation sequencing (NGS). With a strong foundation in machine learning and data mining, Hao has spearheaded several key projects...
Hao Zheng is a visionary leader and the Co-founder and President of 锘崴科技, where he plays a pivotal role in advancing the field of bioinformatics and next-generation sequencing (NGS). With a strong foundation in machine learning and data mining, Hao has spearheaded several key projects that leverage cutting-edge technologies to enhance the accuracy and efficiency of diagnostic solutions. His expertise in IVD software development has been instrumental in guiding the company through complex FDA clearance and PMA submission processes, ensuring that their innovative products meet the highest regulatory standards.
At 锘崴科技, Hao is particularly focused on the applications of liquid biopsy and microbiome analysis, areas that hold immense potential for revolutionizing personalized medicine. By harnessing the power of privacy computing, he is committed to enabling the trustworthy flow of data, which is crucial for unlocking the value of genomic information while maintaining patient confidentiality. His technical skills in R, Perl, SQL, and MongoDB complement his strategic vision, allowing him to lead multidisciplinary teams in developing algorithms that drive pattern recognition and enhance DNA sequencing methodologies.
Hao's dedication to advancing bioinformatics not only positions 锘崴科技 at the forefront of the industry but also contributes to the broader goal of improving healthcare outcomes through innovative data-driven solutions. His ability to bridge the gap between complex scientific concepts and practical applications makes him a key figure in the evolution of modern diagnostics, paving the way for future breakthroughs in the field.
